FLOW CYTOMETRY RESOURCE
流式细胞术资源
基本信息
- 批准号:7862541
- 负责人:
- 金额:$ 16.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:7-aminoactinomycin DAccountingApoptosisAreaArtsBiological AssayBromodeoxyuridineBudgetsBusinessesCancer CenterCancer Center Support GrantCell CycleCell SeparationCell surfaceCellsColorComputer WorkstationsComputer softwareComputersDataData AnalysesData Storage and RetrievalDetectionDyesEquipmentFeesFlow CytometryFlow Cytometry Shared ResourceFluorescenceFluorescence-Activated Cell SortingFluorochromeFundingFutureGenerationsGenesHourImmunophenotypingIndividualLicensingLifeMeasurementMeasuresMutationOperative Surgical ProceduresPeer ReviewPloidiesPopulationProductionPropidium DiiodideProtein AnalysisProteinsResearchResearch PersonnelResourcesReverse Transcriptase Polymerase Chain ReactionScientistServicesSiteSorting - Cell MovementSpeedSterilitySupervisionSystemTechniquesTrainingannexin A5basecell analyzercytokinedesignflexibilityfluorescence activated cell sorter deviceinstrumentmedical specialtiesmemberrelease of sequestered calcium ion into cytoplasmresearch study
项目摘要
A fully Cancer Center-managed facility, the Flow Cytometry Shared Resource assists HICCC members in
flow cytometry-based studies. Services include:
¿ Fluorescence-activated cell sorting (FACS)
¿ Analytical flow cytometry for immunophenotyping
¿ Flow cytometry for analyzing cell cycle and apoptosis
The capacity of the facility has increased substantially over the past three years due to the acquisition of
new instruments. The facility now operates five instruments, including two fluorescence-activated cell
sorters that allow high-speed cell sorting and can detect up to 12 fluorescent parameters, and one
advanced cell analyzer that besides multi-color fluorescence is able to perform specialty applications such
as determination of DMA content, multiple (living color) fluorescent protein analysis and calcium flux
measurements. In addition to those sophisticated instruments, the facility provides access to two useroperated
basic cytometers permitting 3 or 4 color immunophenotyping, respectively, as well as cell cycle
and apoptosis assays. Over the last several years, the services of the facility have benefited 130 CUMC
investigators, with HICCC members comprising the main users of the instruments accounting for ~60%.
The high usage volume allows the facility to offer the services at low fees, which are further reduced for
HICCC members. The sophisticated equipment available in the facility allows investigators at Columbia to
perform state-of-the-art research in the area of flow cytometry, and therefore represent a vital resource for
HICCC members. In the future, we plan to upgrade the flow cytometers to facilitate detection and sorting of
newly developed living color fluorescent proteins and to purchase an instrument that serves as a flexible
analysis platform for additional fluorescence-based techniques, including cytometric bead assays (CBA) to
measure cytokine production, among other potential applications.
During the last period of the CCSG, 36% of the investigators using the facility were Cancer Center
members with peer-reviewed funding, with those members representing from 50% to 66% of the usage of
the 3 available services. The proposed total operating budget of the facility is $425,004, of which we are
requesting $ 116,271 from the CCSG
作为一个完全由癌症中心管理的机构,流式细胞术共享资源帮助HICCC成员
基于流式细胞术的研究。服务包括:
荧光激活细胞分选(FACS)
·流式细胞术用于免疫表型分析
流式细胞术分析细胞周期和细胞凋亡
该设施的产能在过去三年中由于收购了
新乐器。该设施现在运行着五台仪器,包括两台荧光激活的细胞
允许高速细胞分选并可以检测多达12个荧光参数的分选器,以及一个
先进的细胞分析仪,除了多色荧光外,还能够执行特殊应用,如
作为DMA含量的测定,多重(活体)荧光蛋白分析和钙离子通量
测量。除了这些复杂的仪器外,该设施还提供两个用户操作的通道
基础细胞仪分别允许3色或4色免疫表型以及细胞周期
并进行细胞凋亡检测。在过去的几年里,该设施的服务使130个中央管理委员会受益
调查人员,其中HICCC成员是仪器的主要用户,约占60%。
高使用量使设施能够以较低的费用提供服务,费用将进一步降低
HICCC成员。该设施中可用的尖端设备使哥伦比亚大学的调查人员能够
在流式细胞术领域进行最先进的研究,因此是
HICCC成员。未来,我们计划升级流式细胞仪,以方便检测和分选
新开发的活的彩色荧光蛋白和购买一台仪器,作为一种灵活的
用于其他基于荧光的技术的分析平台,包括细胞学珠粒分析(CBA)
测量细胞因子的产生,以及其他潜在的应用。
在CCSG的最后一段时间里,使用该设施的调查人员中有36%是癌症中心
有同行审查资金的成员,这些成员占使用情况的50%至66%
可提供的3项服务。该设施的拟议总运营预算为425,004美元,其中我们
向CCSG索要116,271美元
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ULF KLEIN其他文献
ULF KLEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ULF KLEIN', 18)}}的其他基金
Role of IRF4-NOTCH2 Interplay in B-Cell Development and Malignancy
IRF4-NOTCH2 相互作用在 B 细胞发育和恶性肿瘤中的作用
- 批准号:
8625730 - 财政年份:2013
- 资助金额:
$ 16.79万 - 项目类别:
Role of IRF4-NOTCH2 Interplay in B-Cell Development and Malignancy
IRF4-NOTCH2 相互作用在 B 细胞发育和恶性肿瘤中的作用
- 批准号:
8489575 - 财政年份:2013
- 资助金额:
$ 16.79万 - 项目类别:
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
NF-kB 在 B 细胞分化和淋巴瘤发生中的作用
- 批准号:
8998932 - 财政年份:2012
- 资助金额:
$ 16.79万 - 项目类别:
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
NF-kB 在 B 细胞分化和淋巴瘤发生中的作用
- 批准号:
8237352 - 财政年份:2012
- 资助金额:
$ 16.79万 - 项目类别:
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
NF-kB 在 B 细胞分化和淋巴瘤发生中的作用
- 批准号:
8823740 - 财政年份:2012
- 资助金额:
$ 16.79万 - 项目类别:
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
NF-kB 在 B 细胞分化和淋巴瘤发生中的作用
- 批准号:
8435388 - 财政年份:2012
- 资助金额:
$ 16.79万 - 项目类别:
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
NF-kB 在 B 细胞分化和淋巴瘤发生中的作用
- 批准号:
8613313 - 财政年份:2012
- 资助金额:
$ 16.79万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 16.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 16.79万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 16.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 16.79万 - 项目类别:
Standard Grant
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 16.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 16.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 16.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 16.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 16.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 16.79万 - 项目类别: